These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Plasma concentration of biochemical markers in pre-eclampsia-eclampsia and its association with the severity of the disease]. Chavarría Olarte ME, González Gleason A, Lara González AL, Sojo Aranda I, García Paleta Y, Vital Reyes VS, Reyes Fuentes A. Ginecol Obstet Mex; 2000 Sep; 68():385-93. PubMed ID: 11080945 [Abstract] [Full Text] [Related]
44. Maternal and perinatal outcome in severe pregnancy-related liver disease. Pereira SP, O'Donohue J, Wendon J, Williams R. Hepatology; 1997 Nov; 26(5):1258-62. PubMed ID: 9362370 [Abstract] [Full Text] [Related]
45. Comparison of placental pathology between severe preeclampsia and HELLP syndrome. Mehrabian F, Mohammadizadeh F, Moghtaderi N, Najafian A. Arch Gynecol Obstet; 2012 Jan; 285(1):175-81. PubMed ID: 21698449 [Abstract] [Full Text] [Related]
46. [Clinical and chemical laboratory course of HELLP syndrome--a retrospective analysis]. Schwerk C, Schmidt-Rhode P, Zimmermann M, Hackenberg R, Prinz H. Z Geburtshilfe Neonatol; 1996 Jan; 200(3):109-14. PubMed ID: 8963882 [Abstract] [Full Text] [Related]
47. Expectant management of severe preeclampsia presenting before 25 weeks of gestation. Sezik M, Ozkaya O, Sezik HT, Yapar EG. Med Sci Monit; 2007 Nov; 13(11):CR523-527. PubMed ID: 17968301 [Abstract] [Full Text] [Related]
48. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Ganzevoort W, Rep A, de Vries JI, Bonsel GJ, Wolf H, PETRA-investigators. Am J Obstet Gynecol; 2006 Aug; 195(2):495-503. PubMed ID: 16643825 [Abstract] [Full Text] [Related]
49. Smoking and the risk of developing hypertensive diseases in pregnancy: what is the effect on HELLP syndrome? Leeners B, Neumaier-Wagner P, Kuse S, Rath W. Acta Obstet Gynecol Scand; 2006 Aug; 85(10):1217-24. PubMed ID: 17068681 [Abstract] [Full Text] [Related]
50. BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier-Wagner P. Clin Sci (Lond); 2006 Jul; 111(1):81-6. PubMed ID: 16579791 [Abstract] [Full Text] [Related]
51. [The impact of pregnancy-prolonging management on maternal and neonatal morbidity in HELLP syndrome]. Hagen A, Ebert A, Lange J, Zemlin M, Hopp H. Zentralbl Gynakol; 2001 Sep; 123(9):513-9. PubMed ID: 11709744 [Abstract] [Full Text] [Related]
52. Moderate to severe thrombocytopenia during pregnancy. Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, Holcberg G, Yerushalmi R. Eur J Obstet Gynecol Reprod Biol; 2006 Sep; 128(1-2):163-8. PubMed ID: 16533554 [Abstract] [Full Text] [Related]
53. Are we increasing serious maternal morbidity by postponing termination of pregnancy in severe pre-eclampsia/eclampsia? Thomas T, Jophy R, Mhaskar A, Misquith D. J Obstet Gynaecol; 2005 May; 25(4):347-51. PubMed ID: 16091314 [Abstract] [Full Text] [Related]
54. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Martin JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Obstet Gynecol; 2005 Feb; 105(2):246-54. PubMed ID: 15684147 [Abstract] [Full Text] [Related]
55. Vasospasms are characteristic in cases with eclampsia/preeclampsia and HELLP syndrome: proposal of an angiospastic syndrome of pregnancy. Kobayashi T, Tokunaga N, Isoda H, Kanayama N, Terao T. Semin Thromb Hemost; 2001 Feb; 27(2):131-5. PubMed ID: 11372766 [Abstract] [Full Text] [Related]